A study of the biopharmaceutics and pharmacokinetics of the macrolide antibiotic, erythromycin
Erythromycin, a macrolide antibiotic isolated from Streptomyces erythreus, was first introduced into clinical medicine in 1952. It is active against most gram-positive bacteria, some gram-negative bacteria and is currently the agent of choice for Legionella pneumophila. Erythromycin is an acid-labil...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
Rhodes University
1992
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10962/d1003273 |